Beschreibung
Metabolomic profiling data illustrating changes in serum or fecal metabolite signatures following probiotic-fermented herbal treatment. Discriminating metabolites serve as biomarkers for therapeutic response monitoring.
Figure 33
ChartSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 33: Metabolomic profiling data illustrating changes in serum or fecal metabolite signatures following probiotic-fermented herbal treatment. Discriminating metabolites serve as biomarkers for therapeutic response monitoring.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Metabolomic profiling data illustrating changes in serum or fecal metabolite signatures following probiotic-fermented herbal treatment. Discriminating metabolites serve as biomarkers for therapeutic response monitoring." /> <figcaption>Figure 33. Metabolomic profiling data illustrating changes in serum or fecal metabolite signatures following probiotic-fermented herbal treatment. Discriminating metabolites serve as biomarkers for therapeutic response monitoring.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>